Cargando…
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
Neuropeptide Y (NPY) is found at high concentrations in neural crest-derived tumours and has been implicated as a regulatory peptide in tumour growth and differentiation. Neuroblastomas, ganglioneuromas and phaeochromocytomas with significant concentrations of NPY-like immunoreactivity were investig...
Autores principales: | Bjellerup, P, Theodorsson, E, Jörnvall, H, Kogner, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363490/ https://www.ncbi.nlm.nih.gov/pubmed/10901366 http://dx.doi.org/10.1054/bjoc.2000.1234 |
Ejemplares similares
-
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
por: Ponthan, F, et al.
Publicado: (2001) -
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999) -
Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
por: Carén, H, et al.
Publicado: (2007) -
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
por: Ejeskär, K., et al.
Publicado: (1998) -
Neuropeptide Y and its Y2 Receptor – Potential Targets in Neuroblastoma Therapy
por: Lu, Congyi, et al.
Publicado: (2010)